Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2003-11-26
2010-02-23
Rawlings, Stephen L (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S350000, C530S387300
Reexamination Certificate
active
07667004
ABSTRACT:
Methods are provided for designing and selecting antibodies against human antigens with high affinity and specificity in silico and in vitro. In some particular embodiments, methods are provided for designing and selecting humanized or fully human antibodies against vascular endothelial growth factor (VEGF) with high affinity and specificity. In another aspect of the invention, monoclonal antibodies against VEGF are provided. In particular, humanized or human anti-VEGF monoclonal antibodies are provided with ability to bind to human VEGF with high affinity, inhibit VEGF-induced proliferation of endothelial cells in vitro and inhibit VEGF-induced angiogenesis in vivo. These antibodies and their derivative can be used in a wide variety of applications such as diagnosis, prevention, and treatment of diseases such as cancer, AMD, diabetic retinopathy, and other diseases derived from pathological angiogenesis.
REFERENCES:
patent: 6682736 (2004-01-01), Hanson et al.
patent: 2002/0032315 (2002-03-01), Baca et al.
patent: WO 96/06625 (1996-03-01), None
patent: WO 98/45331 (1998-10-01), None
Rudikoff et al (Proc. Natl. Acad. Sci. USA 1982 vol. 79 p. 1979).
Colman et al (Research in Immunology 1994, 145:33-36).
Schier et al (J. Mol Biol. 1996, 263:551-567).
Paul, Fundamental Immunology, 3rd Edition, 1993, pp. 292-295.
Colman. Research in Immunology, 145:33-36, 1994.
Bendig M. M. Methods: A Companion to Methods in Enzymology, 1995; 8:83-93.
MacCallum et al. J. Mol. Biol., 262, 732-745, 1996.
Casset et al. Biochemical and Biophysical Research Communications, 307:198-205, 2003.
Chothia et al., Structural Determinants in the Sequences of Immunoglobulin Variable Domain, J. Mol. Biol., vol. 278, pp. 457-459, 1998.
Iba et al., Changes in the Specificity of Antibodies Against Steroid Antigens by Introduction of Mutations into Complementarity-Determining Regions of the VHDomain, Protein Engineering, vol. 11, No. 5, pp. 361-370, 1998.
Knappik et al., Fully Synthetic Human Combinatorial Antibody Libraries (HuCAL) Based on Modular Consensus Frameworks and CDRs Randomized with Trinucleotides, J. Mol. Biol., vol. 296, pp. 57-86, 2000.
Mandal, C. et al., “ABGEN A Knowledge-Based Automated Approach for Antibody Structure Modeling”,Nature Biotechnology, vol. 14, Mar. 1996, pp. 323-328.
Borrebaeck, C. et al., “Antibody evolution beyond Nature”,Nature Biotechnology, vol. 20, Dec. 2002, pp. 1189-1190.
Bowie, J. et al., “A Method to Identify Protein Sequences That Fold into a Known Three-Dimensional Structure”,Science, vol. 253, Jul. 1991, pp. 164-170.
Voigt, C. et al., “Computational method to reduce the search space for directed protein evolution”,Proc. Natl. Acad. Sci. USA, vol. 98, No. 7, Mar. 2001, pp. 3778-3783.
Moore, G. et al., “Computational Challenges in Combinatorial Library Design for Protein Engineering”,AIChE Journal, vol. 50, No. 2, Feb. 2004, pp. 262-272.
Kono, H. et al., “Statistical Theory for Protein Combinatorial Libraries. Packing Interactions, Backbone Flexibility, and the Sequence Variability of a Main-chain Structure”,J. Mol. Biol., vol. 306 (2001), pp. 607-628.
Wu, H. et al., “Stepwise in vitro affinity maturation of Vitaxin, an αvβ3-specific humanized mAb”,Proc. Natl. Acad. Sci. USA,vol. 95, May 1998, pp. 6037-6042.
Janway, et al. Structure of the antibody molecule and the immunoglobulin genes. In: Immunobiology. 1994; 3:1-3:3.
Hsieh Mark
Li Yan
Luo Peizhi
Wang Kevin C.
Zhong Pingyu
Abmaxis, Inc.
Duffy Brad
Kohli Vineet
Muthard David A.
Rawlings Stephen L
LandOfFree
Humanized antibodies against vascular endothelial growth factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Humanized antibodies against vascular endothelial growth factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Humanized antibodies against vascular endothelial growth factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4212070